Skip to main content
. 2022 Jul 18;19:190. doi: 10.1186/s12974-022-02552-5

Fig. 4.

Fig. 4.

Ex vivo phagocytosis assays in MDMs and microglia in the post-ischemic brain. For phagocytosis assays, the cells were isolated in the post-ischemic brain of asplenic mice that received GFP + splenocytes and bead580/605 at 6th day after stroke. a Gating strategy for isolated cells containing GFP and /or bead580/605 with subsets P1–P4 containing bead+ phagocytes. b Measures of phagocytic activity in GFP (P1, P3) and GFP+ (P2, P4) cells within the contralateral (P1, P2) and ipsilateral (P3, P4) hemispheres. Phagocytic activity was monitored by counts of cells containing bead580/605 (counts), mean fluorescence intensity (MFI) of bead+ cells, and a phagocytic index (counts x MFI). c Cell count distribution of P1’–P4’ subsets, which contain CD45+/CD11b+/NK1.1/Ly6G microglia and MDMs. d Measures of phagocytic activity for microglia (GFP) and MDMs (GFP+) in the contralateral (P1’, P2’) and ipsilateral (P3’ P4’) hemispheres. Measures of statistical significance were determined by one-way ANOVA with post hoc Bonferroni comparison test (**, ***, and ****, respectively, indicating p < 0.01, 0.001, 0.0001)